Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy

Completed

Conditions studied: Adolescent Depression

In brief

We hypothesize that antipsychotic induced hyperprolactinemia can decrease bone mineral accrual and decrease bone mineral content (BMC) in adolescents on antipsychotic therapy. Specifics Aims 1. To determine if antipsychotic therapy leads to decreased bone mineral accrual and decreased bone mineral content in a group of adolescents on antipsychotic therapy by comparing them to an ethnicity, gender and pubertal stage matched control group. 2. To determine the relationship between serum concentrations of prolactin, sex steroids and bone turnover markers in adolescents on antipsychotic therapy and an ethnicity, gender and pubertal stage matched control group.

Key facts

Study ID
NCT00399776
Run by
Creighton University
People needed
60
Starts
2006-10-01
Expected to finish
2009-09-01
Last updated by the study team
2011-08-04

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.